2020 Pharmaceutical research Side effects 
European Pharmaceutical Review
SEPTEMBER 22, 2023
While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience.
Pharmaceutical Technology
JULY 23, 2008
” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the Pharmaceutical Research and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone.
Expert insights. Personalized for you.
97 
Let's personalize your content